Medicines Optimisation and Physical Health Safety in Mental Health Services: Monitoring That Actually Works

Medicines keep people well, but they can also create significant physical health risk when monitoring is missed, side effects are normalised, or escalation is unclear. In community mental health and supported settings, medicines safety is one of the most practical ways parity of esteem is either delivered or undermined. This article sits within Physical Health, Dual Diagnosis & Parity of Esteem and aligns with Service Models & Care Pathways because monitoring and follow-up only work when they are built into routine pathways, not treated as extra tasks.

Where medicines-related physical health risk goes wrong

Common operational failure points include:

• Monitoring schedules not owned: blood tests and observations are “due” but nobody is accountable for completion and follow-up.
• Outcomes not confirmed: referrals or test requests are made, but results are not reviewed, communicated or acted on.
• Side effects normalised: weight gain, sedation, tremor, constipation, dizziness or sexual dysfunction are accepted as inevitable rather than managed.
• Interactions and substance use: alcohol/drug use increases risk (dehydration, overdose, QT prolongation, falls), but plans do not reflect this.

A parity-focused service designs a monitoring system that works for people with anxiety, trauma histories, cognitive impairment, unstable housing and fluctuating engagement.

Commissioner expectation

Commissioner expectation: Providers demonstrate reliable medicines safety processes that reduce avoidable deterioration and crisis presentations. Commissioners typically expect (1) evidence of monitoring completion and follow-up closure, (2) timely escalation for abnormal results or missed tests, and (3) governance oversight (audit, incidents, learning). In practice, this often means monthly reporting on overdue monitoring and a quality narrative linked to case audits.

Regulator / Inspector expectation (CQC)

Regulator / Inspector expectation (CQC): Medicines are managed safely, people are protected from avoidable harm, and care is person-centred with clear risk management. Inspectors will test whether staff understand monitoring requirements, recognise red flags, record decisions, and act consistently. They will also look for reasonable adjustments so that people are not excluded from safe care due to fear of appointments or difficulties with phlebotomy.

What a “monitoring system” actually needs to include

A credible operational model is more than a list of checks. It needs:

• A single source of truth for monitoring due dates (register/dashboard) with named ownership.
• Escalation rules for missed tests, abnormal results and physical red flags.
• Reasonable adjustment pathways (supported booking, accompaniment, quiet appointments, staged desensitisation).
• Documented follow-up closure (result reviewed, person informed, action taken, plan updated).
• Governance (audit, incident review, supervision prompts and learning actions).

Operational example 1: Lithium monitoring with fluctuating capacity and dehydration risk

Context: A person prescribed lithium experiences periods of low mood and self-neglect. They miss blood tests and sometimes become dehydrated, increasing toxicity risk. Staff are concerned but unsure how to “hold the line” without damaging engagement.

Support approach: The provider implements a lithium safety pathway: clear due dates for levels and renal/thyroid function, escalation steps for missed tests, and a hydration/illness plan. A senior clinician provides oversight where risk escalates.

Day-to-day delivery detail: The care coordinator reviews monitoring status during routine contacts and uses a standard script to explain why tests protect the person (“this keeps your treatment safe”). Appointments are booked with the person present and reminders agreed (text prompts, phone call, staff accompaniment). A “sick day” plan is discussed and recorded: what to do if unwell, vomiting/diarrhoea, or unable to drink fluids; when to seek urgent advice. If the person repeatedly misses tests, escalation is triggered: discussion with prescriber, risk review, and documented decision about whether prescribing can safely continue until monitoring is completed, with proportionality and the person’s wishes recorded. Where capacity is in question at the time of refusal, staff document capacity considerations and seek clinical advice in line with policy.

How effectiveness or change is evidenced: The service evidences monitoring completion rates, time from overdue to completed test, and outcomes of prescriber reviews. Case audits test whether escalation steps were followed and whether the person was informed of results and actions.

Operational example 2: Clozapine physical health risks—constipation, infection and rapid escalation

Context: A person on clozapine reports constipation and lethargy. They also have intermittent fevers but do not want to “bother anyone”. Staff know clozapine carries serious physical health risks but worry about overreacting.

Support approach: The provider implements a clozapine red-flag protocol that includes constipation management, infection risk awareness and immediate escalation routes. Staff training focuses on recognising and acting on red flags, not just recording symptoms.

Day-to-day delivery detail: Staff ask targeted physical health questions in routine contacts (bowel habit, abdominal pain, fever, sore throat, confusion). Constipation is addressed proactively: hydration prompts, dietary adjustments that are realistic, and liaison with the prescribing team/GP for medication review and appropriate treatment. For fever or infection signs, staff follow an immediate escalation process, contacting the relevant clinical team and documenting actions and outcomes. The care plan includes clear instructions for the person and carers (where appropriate) on what symptoms require urgent help, using accessible language and agreed communication methods.

How effectiveness or change is evidenced: Evidence includes documented red-flag checks, clear escalation timelines, and confirmation of clinical outcomes. Governance reviews test whether red flags were escalated consistently and whether learning was captured from incidents or near misses.

Operational example 3: Antipsychotic side effects, falls risk and dual diagnosis interactions

Context: A person prescribed antipsychotics experiences sedation and postural dizziness. Alcohol use increases falls risk and reduces adherence. They have had two recent falls but decline A&E attendance.

Support approach: The provider integrates medicines safety with physical health and dual diagnosis risk management. The plan includes falls risk mitigation, review of side effects with the prescriber, and harm-reduction steps around alcohol use.

Day-to-day delivery detail: Staff document falls, check for injuries and red flags, and encourage a GP review with supported booking and accompaniment. Side effects are recorded using consistent descriptors (timing, severity, impact on function) to support a meaningful medication review rather than vague statements. The provider completes a home safety check (lighting, trip hazards) and agrees practical mitigation (slow position changes, hydration, avoiding alcohol with medication where possible). If the person refuses assessment and risk is significant, staff follow safeguarding and escalation procedures, documenting the rationale and proportionality. The plan is reviewed weekly until stability improves.

How effectiveness or change is evidenced: Evidence includes prescriber communications and outcomes (dose adjustment, medication change, additional monitoring), reduced falls incidents, and improved adherence supported by practical routines. Commissioners can see an audit trail that demonstrates active risk management rather than passive signposting.

Governance and assurance mechanisms that stand up to scrutiny

Medicines-related physical health safety must be visible in governance. Strong providers can demonstrate:

• Monitoring registers with overdue action lists and named accountability.
• Monthly audit sampling to test follow-up closure (results reviewed, person informed, action taken).
• Incident and near-miss review focusing on missed deterioration, delayed escalation and system fixes.
• Supervision that explicitly reviews medicines safety decisions and escalation thresholds.

Parity of esteem is evidenced when medicines safety is treated as part of core mental health delivery and the service can show consistent practice across staff and settings.

---